You are not currently logged in.

Access JSTOR through your library or other institution:


Log in through your institution.

Journal Article

Serotonin Syndrome after Concomitant Treatment with Linezolid and Citalopram

L. Bernard, R. Stern, D. Lew and P. Hoffmeyer
Clinical Infectious Diseases
Vol. 36, No. 9 (May 1, 2003), p. 1197
Published by: Oxford University Press
Stable URL:
Page Count: 1
Were these topics helpful?
See something inaccurate? Let us know!

Select the topics that are inaccurate.

  • Download ($42.00)
  • Subscribe ($19.50)
  • Add to My Lists
  • Cite this Item
Preview not available
Preview not available


Linezolid, a new synthetic antimicrobial, is an important weapon against methicillin-resistant Staphylococcus aureus (MRSA). Although there are reports of serotonin syndrome developing after concomitant use of linezolid and the selective serotonin reuptake inhibitor paroxitene, this report concerns a patient receiving citalopram who developed thrombocytopenia, serotonin syndrome, and lactic acidosis and died following long-term linezolid therapy.

Page Thumbnails

  • Thumbnail: Page